Phase II Study of Rituximab Given in Conjunction with Standard Chemotherapy in Primary Central Nervous System Lymphoma (PCNSL)[E1F05]

被引：0

作者：

Swinnen, Lode J. ^{[1
]}

O'Neill, Anne ^{[2
]}

Imus, Philip H. ^{[1
]}

Gujar, Sachin ^{[3
]}

Schiff, David ^{[4
]}

Kleinberg, Lawrence ^{[5
]}

Advani, Ranjana ^{[6
]}

Dunbar, Erin ^{[7
]}

Moore, Dennis F., Jr. ^{[8
]}

Grossman, Stuart ^{[1
]}

机构：

[1] Johns Hopkins, Med Oncol, Baltimore, MD USA

[2] Dana Farber Harvard Canc Ctr, BIostat Core, Cambridge, MA USA

[3] Johns Hopkins, Dept Radiol, Baltimore, MD USA

[4] Univ Virginia, Charlottesville, VA USA

[5] Johns Hopkins, Radiat Oncol, Baltimore, MD USA

[6] Stanford Canc Ctr, Stanford, CA USA

[7] Univ Florida, Gainesville, FL USA

[8] Wichita CCOP, Canc Ctr Kansas, Wichita, KS USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group (E1F05)
Swinnen, Lode J.
O'Neill, Anne
Imus, Philip H.
Gujar, Sachin
Schiff, David
Kleinberg, Lawrence R.
Advani, Ranjana H.
Dunbar, Erin M.
Moore, Dennis
Grossman, Stuart A.
ONCOTARGET, 2018, 9 (01) : 766 - 773
[2] PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) TREATED ONLY WITH CHEMOTHERAPY
Abe, Tatsuya
Sugita, Kenji
Morishige, Masaki
Momii, Yasutomo
Anan, Mitsuhiro
Murata, Kumi
Kamida, Tohru
Hikawa, Takamitsu
Fujiki, Minoru
Kobayashi, Hidenori
NEURO-ONCOLOGY, 2009, 11 (05) : 634 - 635
[3] A PHASE 1B STUDY OF PEMBROLIZUMAB, IBRUTINIB AND RITUXIMAB IN RECURRENT/REFRACTORY (RR) PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
Chukwueke, Ugonma
Wright, Isobel
Muzikansky, Alona
Russ, Alyssa
Fontana, Brittney
Kats, Vanessa
O'Donnell, Colin
Scalfani, Renee
Acevedo-Naranjo, Brenda
Lee, Eudocia
Castro, Luis Nicolas Gonzalez
McFaline-Figueroa, Jose Ricardo
Aquilanti, Elisa
Youssef, Gilbert
Beroukhim, Rameen
Forst, Deborah
Reardon, David
Wen, Patrick
Batchelor, Tracy
Torres, Alexandra
Stefanik, Jennifer
Fisher, Jennifer
Meredith, David
Murakami, Mark
Garcia, Yuri
Shipp, Margaret
Nayak, Lakshmi
NEURO-ONCOLOGY, 2023, 25
[4] The pharmacokinetics of methotrexate with and without rituximab in the treatment of primary central nervous system lymphoma (PCNSL)
Rawat, F. R.
Nolan, A.
Teo, S. Y.
Triggs, M.
Carroll, G.
Picardo, S.
Keegan, N. M.
Mallett, V.
Ismail, I.
Hennessy, B.
Grogan, W.
Breathnach, O.
Morris, P.
ANNALS OF ONCOLOGY, 2016, 27
[5] Phase II trial of temsirolimus for relapsed/refractory primary central nervous system lymphoma (PCNSL)
Kiewe, P.
Martus, P.
Thiel, E.
Grobosch, T.
Schlegel, U.
Herlinger, U.
Dreyling, M.
Schmidt, C.
Korfel, A.
ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 268 - 268
[6] Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma
Nayak, Lakshmi
Abrey, Lauren E.
Drappatz, Jan
Gilbert, Mark R.
Reardon, David A.
Wen, Patrick Y.
Prados, Michael
Deangelis, Lisa M.
Omuro, Antonio
LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 58 - 61
[7] Chemotherapy (CT) alone for primary central nervous system lymphoma (PCNSL) in young patients
Hoang-Xuan, K
Taillandier, L
Chinot, O
Frenay, M
Hildebrand, J
Monjour, A
Broët, P
Poisson, M
Delattre, JY
NEUROLOGY, 1998, 50 (04) : A353 - A353
[8] CHEMOTHERAPY (CT) IN THE TREATMENT OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA (PCNSL) IN AIDS
DEANGELIS, LM
NEUROLOGY, 1993, 43 (04) : A360 - A360
[9] THE IMPACT OF RITUXIMAB COMBINATION CHEMOTHERAPY ON THE CLINICAL OUTCOMES OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): AN UPDATED META-ANALYSIS
Haddad, Philip
Hammoud, Dalia
Gallagher, Kevin
NEURO-ONCOLOGY, 2020, 22 : 84 - 84
[10] Retrospective Study of 48 Cases of Primary Central Nervous System Lymphoma (PCNSL)
Alessandro, Lucas
Pastor Rueda, Jose
Carpani, Federico
Blaquier, Juan
Tognarelli, Sofia
Varela, Francisco
Arakaki, Naomi
Diez, Blanca
Muggeri, Alejandro
NEUROLOGY, 2016, 86

← 1 2 3 4 5 →